{"id":"W4381113775","doi":"10.1007/s12325-023-02568-0","title":"Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review","year":2023,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Sun Pharma; Sanofi Genzyme; Incyte; Eli Lilly and Company; Ortho Dermatologics; Purdue Pharma; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Purdue University","keywords":"Medicine; Adverse effect; Psoriasis; Clinical trial; Psoriatic arthritis; Internal medicine; Dermatology; Population; Intensive care medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002129644,0.0005670097,0.002344636,0.0001616488,0.0001204781,0.000003704565,0.0003211101,0.0002640667,0.00003512712],"category_scores_gemma":[0.00003115852,0.0002857678,0.0004969886,0.0005456703,0.0001327874,0.00008994339,0.00002066391,0.000108766,0.00002331948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001418187,"about_ca_system_score_gemma":0.0001706368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001760203,"about_ca_topic_score_gemma":0.0001033889,"domain_scores_codex":[0.9978046,0.0003931604,0.0009282633,0.0004790265,0.00007377167,0.0003211456],"domain_scores_gemma":[0.9974259,0.001151422,0.000747751,0.0005134723,0.0001415296,0.00001992646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002030217,0.0004945218,0.00005555835,0.003821877,0.001888218,9.957583e-7,0.001183959,0.00002207281,0.000001081905,0.00005683847,0.000181191,0.9902635],"study_design_scores_gemma":[0.004210701,0.002336392,0.00003260328,0.0168114,0.0007977275,0.000001966712,0.0001357404,1.157131e-7,0.0001439141,0.00005851112,0.9751619,0.0003090586],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003368458,0.9914299,0.00002216982,0.00003694221,0.0007077092,0.005771376,0.001635228,0.00002413336,0.00003568385],"genre_scores_gemma":[0.00006259737,0.9954963,0.000100413,0.00003526974,0.00004489665,0.002775062,0.0009877024,0.00006147243,0.0004363391],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9899544,"threshold_uncertainty_score":0.9999595,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03196367031395327,"score_gpt":0.3203321296975279,"score_spread":0.2883684593835746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}